SCAI QIT CME Webinar Series 

The SCAI Quality Improvement Toolkit (SCAI-QIT) was developed by SCAI to provide interventional cardiologists with a tool to practice evidence - based guidelines - driven care. The tools contained in SCAI-QIT help interventional cardiologists and catheterization laboratory teams identify opportunities for improvement and changes that will positively impact patient outcomes.


After completing this program, participants should be able to;

  • Identify appropriate quality improvement programs in catheterization laboratories based on clinical guidelines;
  • Apply evidence-based practice to existing quality improvement programs;
  • Manage laboratories to tailor QI programs to local environments.


In order to view and hear online webinars, your computer and internet connection need to meet certain minimum requirements.

Please check that your computer and software meets or exceeds these specifications:

  • Windows XP, Mac OS X 10.2
  • 1GB of RAM memory
  • CPU 1 GHz
  • Monitor 800x600 pixels (1024x768 strongly recommended)
  • DSL or faster internet connection
  • Up-to-date web browser software, such as FireFox 15+, or Internet Explorer 8+, Safari 4+. IE6 is NOT supported.
  • Adobe Flash Plugin, newest version
  • Working audio card and speakers


The Society for Cardiovascular Angiography and Interventions accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care.

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.



Christopher J. White, M.D., FSCAI (Advisory Board / Board Member: Neovasc; St. Jude; Baxter Cellular Therapy)
Sunil V. Rao, M.D., FSCAI (Consultant: Volcano Corporation; Astra Zeneca; Daiichi Sankyo Lilly; Zoll; Terumo Medical; The Medicines Company. Grants or Research Support: Ikaria; Abbott Vascular)


Steven R. Bailey, MD, FSCAI (Editor-in-Chief: Cathterization and Cardiovascular Interventions; Speakers Bureau: Edwards; BSCI; Research Support: Abbott; SCAI; Advisory Board: Biostar; Bio2)
Thomas M. Bashore, MD, FSCAI (Disclosed no conflict of interest)
James Blankenship, MD, FSCAI (Disclosed no conflict of interest)

Lyndon Box, MD, FSCAI (Disclosed no conflict of interest)

Charles E. Chambers, MD, FSCAI (Disclosed no conflict of interest)

Kirk Garratt, MD, FSCAI (Shareholder: Global Delivery Systems; MedLogics; Arstasis; and Infarct Reduction. Speakers Bureau/Advisory Board/Board Member: Boston Scientific Corp; The Medicines Company; Medtronic; Daiichi-Sankyo, Inc.; Abbott Vascular.)

Kalon Ho, MD, FSCAI (Boston Scientific Corporation: Service on an independent clinical events committee adjudicating events for BSC trials.)

Manesh R. Patel, MD, FSCAI (Grants: NHLB, AHRQ and Johnson & Johnson; Advisory Board/ Board member/Consultant: Baxter; Pleuristem; CSI; Genzyme; Ortho-McNeil Jansen; Astra Zeneca)

Srihari Naidu, MD, FSCAI (Advisory Board/ Board member/Consultant: The Medicines Company; Abiomed, Inc.)

Bonnie H. Weiner, MD, FSCAI (Consultant: Accreditation for Cardiovascular Excellence; ArtiCure; Atheromed; Boston Biomedical Associates; Creganna-Tactx. Shareholder: Imaging Core Lab Services)

Steve Yakubov, MD, FSCAI (Advisory Board/ Board member/Consultant: Medtronic; Boston Scientific; Abbott Vascular; Boehringer Ingleheim. Speakers Bureau: SentreHEART)